Skip to content

Eloxx Pharmaceuticals, Inc.

ELOX ELOXD

CIK 0001035354

← back to feed
Revenue (TTM)
$0
−100.0% YoY Q1 May 2026
Net Income (TTM)
−$13.4M
−90.7% YoY Q1 May 2026
EPS Diluted (TTM)
−$3.80
+41.7% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$20.64M
Q1 May 2026
Cash
$6.36M
Q1 May 2026
Total Debt
$0
Q1 May 2026
Shares Outstanding
7.57M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings